Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Struthers

Showing results (91-100 of 165) with videos related to

Pageof 17
Sort By:
International Journal of Cardiology|March 31, 2012
Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trialMiles D Witham, Fiona J Dove, Faisel Khan, et al.
European Journal of Heart Failure|October 1, 2009
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fractionHari K Parthasarathy, Burkert Pieske, Marianne Weisskopf, et al.
BMC Research Notes|June 17, 2018
Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patientsLouise A Beveridge, Rosemary J G Price, Louise A Burton, et al.
Circulation|September 1, 2020
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF TrialNatalie A Mordi, Ify R Mordi, Jagdeep S Singh, et al.
Cardiovascular Therapeutics|February 12, 2009
Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiologyTiong K Lim, AnnaMaria J Choy, Faisel Khan, et al.
The Lancet Regional Health. Europe|August 21, 2023
Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation frameworkAnthony Chen, Chengsheng Ju, Isla S Mackenzie, et al.
The American Journal of Cardiology|April 22, 2005
Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failureMiles D Witham, Joan M Gray, Ishbel S Argo, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 9, 2020
Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung DiseasePatrick S K Liu-Shiu-Cheong, Brian J Lipworth, Jonathan R Weir-McCall, et al.
Clinical Science (London, England : 1979)|May 20, 2009
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failurePaul R Kalra, Jonathan R Clague, Andrew J Coats, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 16, 2007
Screening for left ventricular systolic dysfunction using GP-reported ECGsBarclay M Goudie, Rob I Jarvis, Peter T Donnan, et al.
Pageof 17

Showing results (91-100 of 165) with videos related to

Sort By:
Pageof 17
International Journal of Cardiology|March 31, 2012
Effects of vitamin D supplementation on markers of vascular function after myocardial infarction--a randomised controlled trialMiles D Witham, Fiona J Dove, Faisel Khan, et al.
European Journal of Heart Failure|October 1, 2009
A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fractionHari K Parthasarathy, Burkert Pieske, Marianne Weisskopf, et al.
BMC Research Notes|June 17, 2018
Acceptability and feasibility of magnetic femoral nerve stimulation in older, functionally impaired patientsLouise A Beveridge, Rosemary J G Price, Louise A Burton, et al.
Circulation|September 1, 2020
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF TrialNatalie A Mordi, Ify R Mordi, Jagdeep S Singh, et al.
Cardiovascular Therapeutics|February 12, 2009
Therapeutic development in cardiac syndrome X: a need to target the underlying pathophysiologyTiong K Lim, AnnaMaria J Choy, Faisel Khan, et al.
The Lancet Regional Health. Europe|August 21, 2023
Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a population-based cohort study in target trial emulation frameworkAnthony Chen, Chengsheng Ju, Isla S Mackenzie, et al.
The American Journal of Cardiology|April 22, 2005
Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failureMiles D Witham, Joan M Gray, Ishbel S Argo, et al.
International Journal of Chronic Obstructive Pulmonary Disease|September 9, 2020
Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung DiseasePatrick S K Liu-Shiu-Cheong, Brian J Lipworth, Jonathan R Weir-McCall, et al.
Clinical Science (London, England : 1979)|May 20, 2009
C-type natriuretic peptide production by the human kidney is blunted in chronic heart failurePaul R Kalra, Jonathan R Clague, Andrew J Coats, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 16, 2007
Screening for left ventricular systolic dysfunction using GP-reported ECGsBarclay M Goudie, Rob I Jarvis, Peter T Donnan, et al.
Pageof 17